MEDIROM Healthcare shares surge 13.98% after-hours as controlling shareholder announces JPY 50 million stock repurchase plan.

MEDIROM Healthcare Technologies surged 14.0% in after-hours trading following the announcement by its controlling shareholder and CEO of a stock repurchase plan worth up to JPY 50 million on January 23. This move signals management’s confidence in the stock’s value and aligns with the company’s recent efforts to address regulatory compliance, including regaining Nasdaq listing standards in April 2026. While the stock had previously declined 2.7% on January 14 amid mixed earnings and delayed filings, the latest buyback initiative likely attracted investor optimism by demonstrating financial commitment and addressing liquidity concerns.